ABOUT
NEWS
PLATFORM
PIPELINE
TEAM
CONTACT
Back
PLATFORM
Publications
ABOUT
NEWS
PLATFORM
PLATFORM
Publications
PIPELINE
TEAM
CONTACT
THE LATEST
Featured
Apr 1, 2024
Rapafusyn Pharmaceuticals Presents At Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego
Apr 1, 2024
Apr 1, 2024
Feb 1, 2024
Rapafusyn's Dr. Rick Ewing Acknowledged with Dual Honors for Exceptional Achievements
Feb 1, 2024
Feb 1, 2024
Jan 31, 2024
Rapafusyn Pharmaceuticals Presents at The Second Annual Molecular Glue Summit in Boston, MA on January 31 - February 1
Jan 31, 2024
Jan 31, 2024
Mar 23, 2023
Mr. Matthew Gross joins Rapafusyn as Vice President of Business Development
Mar 23, 2023
Mar 23, 2023
Mar 23, 2023
Dr. Rick Ewing joins Rapafusyn as Vice President of Medicinal Chemistry
Mar 23, 2023
Mar 23, 2023
Dec 9, 2022
SAB
Dr. Howard G. Hutchinson joins Rapafusyn's Scientific Advisory Board
Dec 9, 2022
SAB
Dec 9, 2022
SAB
Dec 6, 2022
SAB
Dr. Scott Reines joins Rapafusyn's Scientific Advisory Board
Dec 6, 2022
SAB
Dec 6, 2022
SAB
Nov 22, 2022
SAB
Dr. George P. Vlasuk joins Rapafusyn's Scientific Advisory Board
Nov 22, 2022
SAB
Nov 22, 2022
SAB
Oct 28, 2022
Corporate
Dr. Matthew Olson is promoted to Vice President of Biological Sciences
Oct 28, 2022
Corporate
Oct 28, 2022
Corporate
Oct 1, 2022
SAB
Dr. Alison Schecter joins Rapafusyn's Scientific Advisory Board
Oct 1, 2022
SAB
Oct 1, 2022
SAB
Sep 20, 2022
Corporate
3E Bioventures exercises $7M warrant as part of Series A financing; bringing Rapafusyn's total funding raised to $30M
Sep 20, 2022
Corporate
Sep 20, 2022
Corporate
Sep 1, 2022
Corporate
,
SAB
Dr. Wayne Childers joins Rapafusyn's Scientific Advisory Board and acting co-Head of Medicinal Chemistry
Sep 1, 2022
Corporate
,
SAB
Sep 1, 2022
Corporate
,
SAB
Sep 1, 2022
SAB
Dr. Frank Walsh joins Rapafusyn's Scientific Advisory Board
Sep 1, 2022
SAB
Sep 1, 2022
SAB
Sep 1, 2022
Corporate
,
SAB
Dr. Magid Abou-Gharbia joins Rapafusyn's Scientific Advisory Board and acting Head of Medicinal Chemistry
Sep 1, 2022
Corporate
,
SAB
Sep 1, 2022
Corporate
,
SAB
Aug 1, 2022
SAB
Dr. Winston Wu joins Rapafusyn's Scientific Advisory Board
Aug 1, 2022
SAB
Aug 1, 2022
SAB
Jul 25, 2022
SAB
Dr. Steven Projan joins Rapafusyn's Scientific Advisory Board
Jul 25, 2022
SAB
Jul 25, 2022
SAB
Apr 10, 2022
Corporate
Dr. Matthew Olson joins Rapafusyn as Head of Target Strategy and Assay Development
Apr 10, 2022
Corporate
Apr 10, 2022
Corporate
Apr 8, 2022
SAB
Dr. Steven Bender joins Rapafusyn's Scientific Advisory Board
Apr 8, 2022
SAB
Apr 8, 2022
SAB
Apr 4, 2022
SAB
Dr. Dan Marquess joins Rapafusyn's Scientific Advisory Board
Apr 4, 2022
SAB
Apr 4, 2022
SAB
Jan 24, 2022
Corporate
3E Bioventures exercises $5M warrant as part of Series A financing
Jan 24, 2022
Corporate
Jan 24, 2022
Corporate
Jan 17, 2022
Corporate
Robert Besthof joins Rapafusyn's Advisory Board
Jan 17, 2022
Corporate
Jan 17, 2022
Corporate
Jan 14, 2022
SAB
Dr. Lyn Jones joins joins Rapafusyn's Scientific Advisory Board
Jan 14, 2022
SAB
Jan 14, 2022
SAB
Jan 13, 2022
Corporate
Dr. Scott Dax joins as Head of Preclinical Development
Jan 13, 2022
Corporate
Jan 13, 2022
Corporate
Jan 1, 2022
SAB
Dr. Howard Schulman joins Rapafusyn's Scientific Advisory Board
Jan 1, 2022
SAB
Jan 1, 2022
SAB
Dec 15, 2021
Corporate
,
SAB
Dr. Garry Neil joins Rapafusyn's Steering Committee and Scientific Advisory Board
Dec 15, 2021
Corporate
,
SAB
Dec 15, 2021
Corporate
,
SAB
Oct 1, 2021
Corporate
Rapafusyn appoints Sean X. Hu, Ph.D., MBA as CEO
Oct 1, 2021
Corporate
Oct 1, 2021
Corporate
Jul 15, 2021
SAB
Dr. Derek Maclean joins Rapafusyn's Scientific Advisory Board
Jul 15, 2021
SAB
Jul 15, 2021
SAB
Mar 30, 2021
Corporate
Rapafusyn Board of Directors appoint Gordon Ringold, PhD as Executive Director
Mar 30, 2021
Corporate
Mar 30, 2021
Corporate
Feb 9, 2021
Corporate
Rapafusyn closes series A financing with 3EBioventures
Feb 9, 2021
Corporate
Feb 9, 2021
Corporate
May 22, 2020
Corporate
Dr. Hamid Rabb joins Rapafusyn's Scientific Advisory Board
May 22, 2020
Corporate
May 22, 2020
Corporate